Wed, Jul 30, 2014, 7:30 AM EDT - U.S. Markets open in 2 hrs.

Recent

% | $
Click the to save as a favorite.

Atossa Genetics, Inc. Message Board

  • doing_good123 doing_good123 Jun 26, 2013 1:10 AM Flag

    To see what will happen to ATOS once United, Aetna, Cigna or Kaiser get on board, look at company BEAT

    BEAT is up almost 100% past couple of days when they announced United healthcare will be supporting their cardio product. BEAT is up 10% today too.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Great comparison..But I got a better one...How many people will use their product compared to Atossa?
      But you are overly correct on one matter. You get the support of these folks and you establish a base. But I read the press release and the one striking statement that is the crux of the matter was, " The decision was the result of an extensive view of clinical evidence." This is the mountain Atossa has to climb for the Cignas
      of this world to support them. It is happening as we speak as the greater number of tests give Atossa the clinical data to impress. It's coming.

    • Thanks for doing good analogy my friend! R u in beat?

      Sentiment: Strong Buy

      • 1 Reply to jrdelane
      • The similarities between BEAT and ATOS is uncanny...both were about $70-80 mil market cap, both low traded stocks, both provide medical devices. BEAT is up 85% since June 10th after United healthcare news.
        ATOS has got Millinium healthcare, Healthsmart health, Fisher Health...who is next.
        My thought is that ATOS has a superior product with bigger potential than BEAT.

        Unfortunately no, I was not in BEAT before the spike.

 
ATOS
1.69+0.02(+1.20%)Jul 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.